These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Vinca alkaloid-resistant phenotype in cultured human leukemic lymphoblasts. Beck WT Cancer Treat Rep; 1983 Oct; 67(10):875-82. PubMed ID: 6354435 [No Abstract] [Full Text] [Related]
14. Pharmacokinetic drug interactions of vinca alkaloids: summary of case reports. Chan JD Pharmacotherapy; 1998; 18(6):1304-7. PubMed ID: 9855331 [TBL] [Abstract][Full Text] [Related]
15. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil. Beck WT; Cirtain MC; Look AT; Ashmun RA Cancer Res; 1986 Feb; 46(2):778-84. PubMed ID: 3455678 [TBL] [Abstract][Full Text] [Related]
16. [General observation on drug resistance of cancer cells]. Inaba M Gan To Kagaku Ryoho; 1982 Feb; 9(2):165-76. PubMed ID: 6764100 [TBL] [Abstract][Full Text] [Related]
19. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors]. Tsuruo T Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic selectivity of vinca alkaloids: a role for guanosine 5'-triphosphate? Houghton PJ; Houghton JA; Bowman LC; Hazelton BJ Anticancer Drug Des; 1987 Oct; 2(2):165-79. PubMed ID: 3329524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]